3TOLLEFSON L . Developing new regulatory approaches to antimi-crobial safety [ J ]. J Vet Med B Infect Dis Vet Public Health,[2004] No. 25.f d.
4LANG M,WANG B,LI Q. Analysis of using antimicrobial in 333cases on operative treatment of clean operation [ J ]. 南昌大学学报:医学版,2010,50(9) :40-42.
5RUBIN R H. Surgical wound infection : Epidemiology,pathogenesis,diagnosis and management[ J] . BMC Infect Dis,2006,27(6) :171.
6Ministry of Health, National Administration of Traditional ChineseMedicine. The Guiding Principles of Clinical Application of Anti-bacterials [ Z ] . Medical Adminstration Department of NationalHealth Ministry, [2004],NO. 285:4.
7Dighe AS,Rao A,Coakley AB,et al. Analysis oF laborato ry critical value reporting at a large academic medical cen- ter[J]. Am J Clin Pathol,2006,125(5) :758-764.
8Dighe AS,Jones JB,Parham S,et al. Survey of critical val ue reporting and reduction of fales-p ositive critical value results[J]. Arch Pathol Lab Med, 2008, 132 (10) : 1666-1671.
9Miano B, Wood W.Implementation of the i.v.push method of antibiotic administration using the FOCUS/PDCA approach[J].Home Healthc Nurse,1998,16(12):831-837.
10Schneider P D.FOCUS-PDCA ensures continuous quality improvement in the outpatient setting[J].Oncol Nurs Forum,1997,24(6):966.
